This study explores the multi-level regulatory roles of the lactate metabolism gene network in oral cancer development using machine learning models. Machine learning analysis shows that lactate-related gene expression profiles can effectively distinguish treatment groups from controls (AUC=0.933), with SLC16A1 and KIF2C being key features. Genes like PFKP, LDHA, LDHB, LDHC, and VCAN are highlighted for their biological relevance. PFKP, involved in glycolytic metabolic regulation, is significantly upregulated in oral cancer patients, suggesting its role in tumor metabolic adaptation. VCAN, ranking sixth in feature importance, is associated with increased disease risk and may become a therapeutic target. EP300 exhibits a complex relationship with oral cancer, potentially acting as a tumor suppressor. Enrichment analysis links these genes to the HIF-1 signaling pathway and metabolic reprogramming. These findings advance the understanding of lactate metabolism's role in oral cancer and identify potential therapeutic targets.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis study did not receive any funding
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data AvailabilityAll data produced are available online at GWAS catalog (https://www.ebi.ac.uk/gwas/) and Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/)
Comments (0)